MUCOPOLYSACCHARIDOSIS I

Clinical trials for MUCOPOLYSACCHARIDOSIS I explained in plain language.

Never miss a new study

Get alerted when new MUCOPOLYSACCHARIDOSIS I trials appear

Sign up with your email to follow new studies for MUCOPOLYSACCHARIDOSIS I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for easing debilitating pain in rare genetic diseases

Symptom relief Ongoing

This study is testing whether a medication called adalimumab can help reduce joint pain and improve movement in children and adults with mucopolysaccharidosis (MPS) types I, II, or VI. These are rare genetic disorders that cause severe joint stiffness and pain. For the first 16 w…

Matched conditions: MUCOPOLYSACCHARIDOSIS I

Phase: PHASE1, PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief

Last updated Mar 23, 2026 15:16 UTC

MUCOPOLYSACCHARIDOSIS I

Get alerted when new MUCOPOLYSACCHARIDOSIS I trials appear

New hope for easing debilitating pain in rare genetic diseases